BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 22074577)

  • 1. The alteration of coagulation in patients with thyroid dysfunction.
    Akinci B; Comlekci A; Ozcan MA
    Recent Pat Endocr Metab Immune Drug Discov; 2011 Jan; 5(1):50-7. PubMed ID: 22074577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thyroid dysfunction and hemostasis: an issue still unresolved.
    Franchini M; Montagnana M; Manzato F; Vescovi PP
    Semin Thromb Hemost; 2009 Apr; 35(3):288-94. PubMed ID: 19452404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.
    Erem C
    Clin Endocrinol (Oxf); 2006 Mar; 64(3):323-9. PubMed ID: 16487444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical review: Thyroid dysfunction and effects on coagulation and fibrinolysis: a systematic review.
    Squizzato A; Romualdi E; Büller HR; Gerdes VE
    J Clin Endocrinol Metab; 2007 Jul; 92(7):2415-20. PubMed ID: 17440013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of thyroid function on the coagulation system and its clinical consequences.
    Elbers LPB; Fliers E; Cannegieter SC
    J Thromb Haemost; 2018 Apr; 16(4):634-645. PubMed ID: 29573126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coagulation and fibrinolysis in thyroid dysfunction.
    Erem C
    Endocrine; 2009 Aug; 36(1):110-8. PubMed ID: 19367377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemostatic changes in thyroid diseases: haemostasis and thrombosis.
    Franchini M
    Hematology; 2006 Jun; 11(3):203-8. PubMed ID: 17325963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subclinical hypothyroidism and homeostatic disturbances: case report and literature review.
    Ehsanzadeh-Cheemeh P; Thompson M; Miller M
    Recent Pat Endocr Metab Immune Drug Discov; 2012 May; 6(2):136-8. PubMed ID: 22435391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Disorders of hemostasis in dysthyroidism].
    Klein M; Barbé F; Kaminsky P; Duc M
    Pathol Biol (Paris); 1993 Mar; 41(3):268-75. PubMed ID: 8332397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thyroid disorders and hypercoagulability.
    Erem C
    Semin Thromb Hemost; 2011 Feb; 37(1):17-26. PubMed ID: 21249601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Thyroid and hemostasis].
    Franchini M
    Recenti Prog Med; 2006 May; 97(5):267-71. PubMed ID: 16838559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood coagulation and fibrinolytic activity in hypothyroidism.
    Erem C; Kavgaci H; Ersöz HO; Hacihasanoglu A; Ukinç K; Karti SS; Deger O; Telatari M
    Int J Clin Pract; 2003 Mar; 57(2):78-81. PubMed ID: 12661786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemostasis and thyroid diseases revisited.
    Franchini M
    J Endocrinol Invest; 2004 Oct; 27(9):886-92. PubMed ID: 15648557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Both exogenous subclinical hyperthyroidism and short-term overt hypothyroidism affect myocardial strain in patients with differentiated thyroid carcinoma.
    Abdulrahman RM; Delgado V; Hoftijzer HC; Ng AC; Ewe SH; Marsan NA; Holman ER; Hovens GC; Corssmit EP; Romijn JA; Bax JJ; Smit JW
    Thyroid; 2011 May; 21(5):471-6. PubMed ID: 21417919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemostatic and fibrinolytic abnormalities in endocrine diseases: a narrative review.
    Targher G; Pichiri I; Zoppini G; Bonora E; Chonchol M
    Semin Thromb Hemost; 2009 Oct; 35(7):605-12. PubMed ID: 20013527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The spectrum of coagulation abnormalities in thyroid disorders.
    Vescovi PP; Favaloro EJ; Lippi G; Garofano M; Montagnana M; Manzato F; Franchini M
    Semin Thromb Hemost; 2011 Feb; 37(1):7-10. PubMed ID: 21249600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of pituitary and thyroid disorders on haemostasis: potential clinical implications.
    Kyriakakis N; Lynch J; Ajjan R; Murray RD
    Clin Endocrinol (Oxf); 2016 Apr; 84(4):473-84. PubMed ID: 25753252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of thyroid hormone on the cardiovascular system.
    Fazio S; Palmieri EA; Lombardi G; Biondi B
    Recent Prog Horm Res; 2004; 59():31-50. PubMed ID: 14749496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Euglobulinic fibrinolysis in hyperthyroidism and hypothyroidism].
    Girolami A; Brunetti A; Lazzarin M
    Folia Endocrinol; 1968 Jun; 21(3):373-84. PubMed ID: 5756116
    [No Abstract]   [Full Text] [Related]  

  • 20. Hyperthyroidism and venous thrombosis: a casual or causal association? A systematic literature review.
    Franchini M; Lippi G; Targher G
    Clin Appl Thromb Hemost; 2011 Aug; 17(4):387-92. PubMed ID: 20308227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.